Cargando…
P081 Azole-resistant Aspergillus fumigatus among NIH hospitalized patients with underlying primary immunodeficiencies
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Aspergillus fumigatus causes a variety of diseases in humans. The drugs recommended for treatment of Aspergillus diseases are the mold-active azole antifungals. However, a wide range of mutations in A. fumigatus confers azole re...
Autores principales: | Seyedmousavi, Amir, Youn, Jung-Ho, Khil, Pavel, Shahegh, Sherin, Kwon-Chung, K.J., Zelazny, Adrian, Lionakis, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509810/ http://dx.doi.org/10.1093/mmy/myac072.P081 |
Ejemplares similares
-
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies
por: Aneke, Chioma, et al.
Publicado: (2022) -
Azole-Resistant Aspergillus fumigatus, Iran
por: Seyedmousavi, Seyedmojtaba, et al.
Publicado: (2013) -
S10.4a New mechanism and detection methods for azole-resistant Aspergillus fumigatus
por: Watanabe, Akira, et al.
Publicado: (2022) -
Aneuploidy Is Associated with Azole Resistance in Aspergillus fumigatus
por: Khateb, Aiah, et al.
Publicado: (2023) -
P039 Cross-resistance to clinical and agricultural azoles among Aspergillus fumigatus strains isolated from humans and environment in Italy
por: Prigitano, Anna, et al.
Publicado: (2022)